In a conversation with Business Today, Dr. Kiran Mazumdar-Shaw highlighted the evolving India-U.S. collaboration in biopharma, with a special focus on the role of AI and the growing potential of biosimilars. She also stressed the need for greater public capital to support the growth of biotech startups in India.
From Volatility To Opportunity: What 2026 Holds For Indian Markets
“True Nationalism Is Self-Reliance”: Gadkari Pushes Innovation, Defence, Clean Energy
“Knowledge Is India’s Capital”: Gadkari Says Converting Innovation Into Wealth Will Shape Nation’s
From Bengaluru To Ayodhya: India Post Transports Priceless Gold-Based Ram Masterpiece
Why Shriram Finance Is Choosing To Stay An NBFC, Not A Bank
